Clinical trials in Levoca

Innovative research focusing on atherosclerotic cardiovascular disease (ASCVD) treatment optimization. Studies aim to evaluate new therapeutic approaches for patients whose current lipid-modifying treatments aren't providing sufficient results.

• Cardiovascular event prevention
• Lipid management therapy
• Arterial plaque reduction

Research emphasizes improving outcomes for patients with advanced cardiovascular conditions.

Comprehensive research into ischemic stroke prevention, particularly focusing on innovative treatments for patients who have experienced acute non-cardioembolic strokes or high-risk transient ischemic attacks.

• Post-stroke treatment optimization
• Blood clot prevention
• Antiplatelet therapy enhancement

Studies evaluate new oral medications against established treatments to improve patient outcomes.

Advanced research targeting atrial fibrillation complications, with a focus on preventing stroke and systemic embolism in at-risk patients.

• Stroke prevention in AF patients
• Bleeding risk management
• Comparative treatment efficacy

Investigations aim to establish superior treatment options with improved safety profiles.

Critical research addressing refractory status epilepticus (RSE), evaluating new therapeutic interventions combined with standard care protocols.

• Emergency seizure management
• Treatment resistance
• Novel therapeutic approaches

Studies focus on developing more effective treatments for severe seizure conditions.